ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Geriatric Medicine

Top Geriatric Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KEITH LERNER MD

Geriatric Medicine

9,736

$420K

439
406 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

JUAN GONZALEZ M.D.

Geriatric Medicine

9,369

$372K

563
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $56

DIEGO FALLON MD

Geriatric Medicine

9,248

$714K

374
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$77
Average prescription price

Avg: $56

GREGORY GIBSON MD

Geriatric Medicine

9,139

$446K

485
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

JULIE ZHU MD

Geriatric Medicine

9,110

$491K

355
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

RAMANABABU PALADUGU M.D.

Geriatric Medicine

9,026

$412K

412
364 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $56

C. MORRISON M.D.

Geriatric Medicine

8,229

$444K

479
457 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

ALAN GOMER M.D

Geriatric Medicine

8,183

$643K

891
868 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $56

CLAUDIO BOCADO M.D.

Geriatric Medicine

8,144

$499K

225
198 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

VANESSA VEVE M.D

Geriatric Medicine

8,064

$314K

638
462 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

MICHAEL BLOCK D.O.

Geriatric Medicine

8,019

$361K

331
319 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

ANGEL HERRERA MD

Geriatric Medicine

8,009

$599K

501
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $56

ALIX GAY MD

Geriatric Medicine

7,846

$338K

376
301 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

YAVIR ESCOVAR M.D.

Geriatric Medicine

7,815

$457K

324
284 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

WINSTON EVALLE M.D.

Geriatric Medicine

7,774

$457K

689
671 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $56

ROBERT MIDENCE MD

Geriatric Medicine

7,725

$516K

550
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

SYEDA RIZVI MD

Geriatric Medicine

7,691

$335K

700
515 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

DEVEN DAVE M.D.

Geriatric Medicine

7,588

$406K

354
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

WILLIAM KROCKTA MD

Geriatric Medicine

7,508

$362K

175
142 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $56

SHEILA CARBONELL MD

Geriatric Medicine

7,309

$297K

323
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $56

JAMES FLOYD D.O.

Geriatric Medicine

7,158

$350K

385
333 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

RAFAEL COTT M.D.

Geriatric Medicine

7,126

$460K

370
358 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

OBAYEDUR KHAN MD

Geriatric Medicine

7,120

$610K

488
478 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $56

ROBERT BONDURANT M.D.

Geriatric Medicine

7,097

$312K

166
136 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

DEBORAH FRIEDLANDER M.D.

Geriatric Medicine

6,910

$436K

508
456 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank